Bimatoprost Eye Drops Ophthalmic Solution 0.03%

Overview: Bimatoprost 0.03% is a prostaglandin analog eye medication. It is used to lower intraocular pressure (reduce fluid buildup) in open-angle glaucoma or ocular hypertension. The same 0.03% solution is also marketed as Latisse for eyelash hypotrichosis (promoting eyelash growth). In practice, 2.5 mL bottles (containing 75 μg of bimatoprost) are commonly used for glaucoma (e.g. Lumigan®). The solution is clear and colorless. Bimatoprost ophthalmic solution should be used only under a doctor’s prescription; it is not an over-the-counter drop. Brand names include Lumigan® (glaucoma) and Latisse® (eyelash growth).

Dosage and Administration

• Glaucoma/Ocular Hypertension: Instill one drop in the affected eye(s) once daily in the evening. Do not exceed once-daily dosing (more frequent use reduces efficacy). Therapy is long-term; onset of pressure reduction begins ~4 hours after dosing, with a peak effect around 8–12 hours. If both eyes are treated, use separate drops. When using multiple ophthalmic medications, wait at least 5 minutes between different drops. Remove soft contact lenses prior to instillation (bimatoprost contains benzalkonium chloride which can absorb into lenses), and lenses may be reinserted 15 minutes after the drop.
• Eyelash Growth (Hypotrichosis): If prescribed for lashes (Latisse®), clean eyelid skin and apply with the provided sterile eyelash applicator nightly to the base of the upper eyelashes. Blot any excess, and dispose of the applicator after one use (use a new applicator for the other eye). Do not apply to the lower lid. Results appear after 8–12 weeks of nightly use, and effects reverse after stopping. (The 2.5 mL bottle contains more solution than a typical lash kit, so it is intended for ocular use.)
• General: Shake well before use. Wash hands before instilling drops. Tilt the head back, gently pull down the lower eyelid, and instill one drop into the eye. Close eye and apply gentle pressure to the inner corner for 1 – 2 minutes. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Each bottle is multi-use; do not share with others.

Storage and Handling

Store unopened bottles at controlled room temperature (36–77°F or 2–25°C). Do not refrigerate or freeze. Protect from heat and direct sunlight; do not store in hot or damp places. After opening, continue using the drop until the expiration date stamped on the bottle (no special short-term discard date is needed). Discard the bottle if it becomes cloudy or changed in appearance. Keep out of reach of children.

Side Effects and Precautions

• Common Ocular Side Effects: Patients frequently experience conjunctival hyperemia (red eyes) – observed in about 15–45% of users. Other relatively common effects include eye itching, burning, dryness, irritation, and visual disturbance (usually mild). Eyelash growth or darkening often occurs as expected (particularly with long-term use). These generally resolve after stopping the medication.
• Pigmentation/Lid Changes: Bimatoprost can cause increased brown pigmentation of the iris and eyelid skin. Increased iris pigmentation (often seen as a browning of the eye color) may develop slowly over months and is likely permanent. Darkening of the eyelid skin (and increased eyelash pigmentation) can occur; eyelid changes are often reversible after discontinuation. Patients should be counseled about this effect before starting therapy.
• Eyelash Changes: Eyelashes on treated eyes may gradually become longer, thicker, darker, or more numerous. Eyes may appear uneven if only one eye is treated. These changes are usually reversible after treatment stops.
• Inflammation and Edema: Use with caution in patients with active intraocular inflammation (uveitis) or risk factors for macular edema (e.g. aphakia, torn lens capsule). Rarely, bimatoprost can exacerbate inflammation. If vision suddenly worsens, or patients develop eye pain/redness not attributable to glaucoma, they should seek medical attention.
• Infection Risk: Because microbial contamination of eye drops can cause serious infection, patients must avoid touching the dropper tip to the eye or any other surface. Do not use the drops if the solution changes color or contains particles. If an eye infection or other ocular surgery occurs, consult your doctor about continuing bimatoprost.
• Contact Lenses: As noted, remove lenses prior to instillation. Wait at least 15 minutes before reinserting lenses.
• Drug Interactions: Concomitant use of other prostaglandin analog eye drops (e.g. latanoprost) may reduce effectiveness; patients using multiple IOP-lowering agents should be monitored. When used with other topical drugs, separate by several minutes. No significant systemic drug interactions are reported due to minimal systemic absorption.
• Contraindications: Do not use bimatoprost if you have a known hypersensitivity to it or any component of the formulation. Not for treating acute episodes of glaucoma or active eye infections.
• Special Populations: Use in children below 16 years is generally not recommended (safety data are limited and risk of pigment changes is unknown). Elderly patients and pregnant or nursing women should use it only if clearly needed (discuss with doctor). Bimatoprost is pregnancy category C; there are no well-controlled studies in pregnant women.